IVF During Perimenopause: Success Rates & What to Expect

IVF Success Rates During Perimenopause: The Real Numbers

Standard IVF success rate statistics don't capture the perimenopause reality. Here's what the data actually shows for women in various stages of reproductive transition:

• Early perimenopause (STRAW -3a), age 38-41: Live birth rates per cycle range from 15-25% with own eggs, depending on reserve markers
• Late early transition, age 41-43: Live birth rates drop to 8-15% per cycle. Cumulative rates over 3 cycles may reach 25-35%
• Late transition (STRAW -2), age 43+: Own-egg live birth rates fall below 5% per cycle. Most pregnancies at this stage involve donor eggs
• Donor egg IVF during perimenopause: Success rates remain 50-65% per transfer regardless of the recipient's age, because egg quality depends on the donor's age

How Perimenopause Changes IVF Protocols

Standard IVF protocols are designed for women with normal ovarian reserve. During perimenopause, your reproductive endocrinologist will likely modify the approach significantly:

• Higher gonadotropin doses: Typical doses of 225-300 IU may be increased to 450-600 IU to stimulate remaining follicles more aggressively
• Antagonist protocols preferred: Shorter protocols that reduce the risk of premature ovulation, which is more common with elevated baseline FSH
• Mini-IVF (minimal stimulation): Uses lower medication doses or clomiphene/letrozole. Yields fewer eggs but potentially better quality, with less physical strain
• Natural cycle IVF: No stimulation medications—retrieves the single egg your body selects naturally. Lower success per cycle but minimal cost and side effects
• Dual trigger: Combining GnRH agonist and hCG trigger may improve egg maturation in poor responders
• Luteal phase support: More aggressive progesterone support is standard, as perimenopause often involves inadequate luteal function

PGT-A Testing: Essential During Perimenopause

Preimplantation Genetic Testing for Aneuploidy (PGT-A) becomes critically important during perimenopause. The high rate of chromosomally abnormal embryos means that transferring untested embryos often leads to failed implantation, miscarriage, or rarely, chromosomal conditions:

• At age 40, roughly 60% of embryos are aneuploid (chromosomally abnormal)
• At age 43, this rises to 80-90%
• PGT-A identifies euploid (chromosomally normal) embryos before transfer
• Transferring a PGT-A-normal embryo has a 60-70% implantation rate regardless of maternal age
• The trade-off: you may go through multiple cycles before finding a normal embryo

When to Consider Donor Eggs

The transition from own-egg IVF to donor egg IVF is deeply personal. Here are clinical indicators that it may be time to expand your options:

• Multiple cycles with no euploid embryos: If 2-3 cycles produce no PGT-A-normal embryos, the probability of success with own eggs is very low
• AMH undetectable and AFC < 3: Stimulation is unlikely to yield meaningful egg numbers
• Consistent poor response: Fewer than 3 eggs retrieved despite maximum stimulation doses
• Age 43+: While individual variation exists, population data shows very low own-egg success beyond this age
• Emotional and financial exhaustion: When the process is no longer sustainable for your wellbeing, donor eggs offer a dramatically higher success rate

Key takeaways

• Own-egg IVF success rates during perimenopause range from 5-25% per cycle depending on stage and markers
• Modified protocols (mini-IVF, antagonist, dual trigger) optimize results for diminished reserve
• PGT-A testing is essential to avoid transferring aneuploid embryos, which increase sharply with age
• Donor egg IVF maintains 50-65% success rates regardless of the recipient's perimenopause stage
• Pursuing own-egg and donor egg tracks simultaneously preserves options while minimizing time lost